Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes
University of California, Davis · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCT07176793
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 10
- US sites recruiting
- 1
- Study start
- March 23, 2026
- Record last updated
- September 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The investigators will use implementation methods to develop better breastfeeding support for patients with gestational diabetes as a way to prevent type 2 diabetes.
Being studied: Implementation mapping to develop a multilevel health system strategy for prevention of type 2 diabetes through targeted breastfeeding support for patients with gestational diabetes
Conditions: Gestational Diabetes Mellitus (GDM); Diabetes Type 2; Breastfeeding Continuation; Breastfeeding Support
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- ≥18 years old and able to communicate in English
- Fits into one of the following:
- patients with GDM who are recently pregnant and/or postpartum;
- health care providers (nurses, physicians, lactation consultants, etc.) who would implement the strategy
- executive leadership
Exclusion Criteria
- Subjects not meeting the inclusion criteria will be considered ineligible for participation
Recruiting US locations
UC Davis Medical Center
Sacramento, CA 95817
Site contact: Elva Horath, MD
Study contacts (from the official record)
- Adrienne Hoyt-Austin, DO, MAS, IBCLC · 916-734-4580 · aehoyt@health.ucdavis.edu
- Elva T Horath, MD · 510-910-4443 · ethorath@health.ucdavis.edu
Similar studies in California
All diabetes studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
TIXiMED, Inc.
- Location
- Chula Vista, CA
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
Regeneron Pharmaceuticals
- Location
- Glendale, CA
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of…
AstraZeneca
- Location
- Glendale, CA + 3 other US sites
- Eligibility basics
- Ages 18–75